Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.53 | 0.0005 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |